O'SHAUGHNESSY ASSET MANAGEMENT, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
O'SHAUGHNESSY ASSET MANAGEMENT, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2020$4,000
-95.8%
1,575
-94.7%
0.00%
-100.0%
Q3 2020$95,000
+9.2%
29,9750.0%0.00%0.0%
Q2 2020$87,000
-62.3%
29,975
-63.3%
0.00%
-62.5%
Q1 2020$231,000
-54.9%
81,761
-48.3%
0.01%
-27.3%
Q4 2019$512,000
+6.7%
158,066
-28.9%
0.01%0.0%
Q3 2019$480,000
-31.5%
222,327
-0.7%
0.01%
-31.2%
Q2 2019$701,000
+117.0%
223,786
+156.6%
0.02%
+100.0%
Q1 2019$323,000
+6360.0%
87,227
+4327.8%
0.01%
Q4 2017$5,000
-99.8%
1,970
-99.7%
0.00%
-100.0%
Q3 2017$2,165,000
+9313.0%
638,776
+6859.1%
0.05%
+4900.0%
Q2 2017$23,000
+4.5%
9,179
-6.6%
0.00%0.0%
Q1 2017$22,000
-70.3%
9,825
-71.7%
0.00%
-50.0%
Q4 2016$74,000
-92.0%
34,770
-87.5%
0.00%
-90.9%
Q3 2016$930,000
+1424.6%
277,682
+1318.9%
0.02%
+1000.0%
Q2 2016$61,000
-16.4%
19,570
-15.6%
0.00%0.0%
Q1 2016$73,000
-94.3%
23,184
-93.6%
0.00%
-93.8%
Q4 2015$1,275,000
-48.6%
360,262
-26.9%
0.03%
-38.5%
Q3 2015$2,480,000
+1255.2%
493,122
+1628.3%
0.05%
+1200.0%
Q2 2015$183,000
+731.8%
28,533
+821.6%
0.00%
Q1 2015$22,000
-69.4%
3,096
-66.6%
0.00%
-100.0%
Q4 2014$72,000
+5.9%
9,282
+1.9%
0.00%0.0%
Q3 2014$68,000
-22.7%
9,109
-0.3%
0.00%
-50.0%
Q2 2014$88,000
+51.7%
9,132
+30.2%
0.00%
+100.0%
Q1 2014$58,000
+34.9%
7,012
+38.4%
0.00%0.0%
Q4 2013$43,000
-97.5%
5,068
-97.7%
0.00%
-97.6%
Q3 2013$1,731,000
-47.4%
217,498
-48.9%
0.04%
-52.3%
Q2 2013$3,293,000425,4760.09%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Silver Point Capital L.P. 23,783,273$58,745,0006.82%
Park West Asset Management LLC 14,397,212$35,561,0000.74%
GABELLI & Co INVESTMENT ADVISERS, INC. 633,700$1,565,0000.24%
JBF Capital, Inc. 543,990$1,344,0000.22%
Context Capital Management, LLC 465,172$1,149,0000.16%
Bellecapital International Ltd. 108,025$267,0000.09%
FNY Investment Advisers, LLC 100,000$247,0000.07%
WINTON GROUP Ltd 291,360$720,0000.05%
Freedom Investment Management, Inc. 54,735$135,0000.02%
HANCOCK WHITNEY CORP 187,757$464,0000.02%
View complete list of PDL BIOPHARMA INC shareholders